Article Information
History
- April 16, 2022.
Article Versions
- You are currently viewing Version 1 of this article (April 16, 2022 - 11:16).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- Roshna Agarwal1,
- Tyler Leblond1,
- Erin M McAuley1,
- Ezekiel J Maier1,
- Martin Skarzynski1,
- Jameson D Voss2 and
- Shanmuga Sozhamannan3,4,*
- 1Booz Allen Hamilton, Bethesda, MD 20814, USA
- 2US Air Force Medical Readiness Agency, Falls Church, VA 22042, USA
- 3Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), Joint Project Lead for CBRND Enabling Biotechnologies (JPL CBRND EB), Frederick, MD 21702, USA
- 4Logistics Management Institute, Tysons, VA 22102, USA
- ↵*Corresponding author; email: shanmuga.sozhamannan.ctr{at}army.mil